Skip to main content

Table 1 Summary of the combined inflammatory factor for HAIC in HCC

From: Predictive factors and prognostic models for Hepatic arterial infusion chemotherapy in Hepatocellular carcinoma: a comprehensive review

Investigator

year

No. of case

Parameters

Cutoff

Nomogram AUC

Takaya [108]

2020

72

VA

2.70

NA

Zeng [153]

2023

152

CCPS

NA

0.735

Zhao [79]

2023

124

MLR

0.57

0.621

Xiao [110]

2023

88

NLR

3.46

NA

Tang [21]

2023

55

NLR

3.82

NA

Li [72]

2024

119

NLR

3.20

NA

Zhao [79]

2023

124

PNI

46.85

0.746

Deng [224]

2024

424

SII

609.9

NA

Deng [224]

2024

424

SIRI

713.05

NA

Wu [165]

2023

415

SIS

−0.227

0.760

  1. HAIC hepatic arterial infusion chemotherapy, HCC hepatocellular carcinoma, No., number, AUC area under curve, VA von Willebrand factor / a disintegrin and metalloproteinase with thrombospondin motifs 13, NA not available, CCPS Cholesterol and C-reactive protein Prognostic Score, MLR monocyte-to-lymphocyte ratio, NLR neutrophil-to-lymphocyte ratio, PNI prognostic nutritional index, SII systemic immune-inflammation index, SIRI systemic inflammation response index, SIS systemic inflammation score